NCT00732589

Brief Summary

The purpose of this study is to compare suprascapular nerve block with therapeutic ultrasound in stroke patients who have shoulder pain in weak side.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Timeline
Completed

Started Aug 2008

Shorter than P25 for phase_2

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2008

Completed
7 days until next milestone

First Submitted

Initial submission to the registry

August 8, 2008

Completed
4 days until next milestone

First Posted

Study publicly available on registry

August 12, 2008

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2008

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2009

Completed
Last Updated

November 18, 2009

Status Verified

August 1, 2008

Enrollment Period

4 months

First QC Date

August 8, 2008

Last Update Submit

November 17, 2009

Conditions

Shoulder PainStroke

Keywords

suprascapular nerve blockshoulder painhemiplegia

Outcome Measures

Primary Outcomes (1)

  • VAS score of pain

    4 weeks after intervention

Secondary Outcomes (1)

  • Range of motion of the shoulder joint

    4 weeks after intervention

Study Arms (2)

A

EXPERIMENTAL

Suprascapular nerve block

Drug: 1% xylocaine

B

EXPERIMENTAL

therapeutic ultrasound

Other: ultrasound

Interventions

1% xylocaineDRUG

10 cc. of 1%xylocaine, once a week

Also known as: suprascapular nerve block
A
ultrasoundOTHER

ultrasound at shoulder area about 10 mins.

Also known as: therapeutic ultrasound
B

Eligibility Criteria

Sexfemale
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Stroke patients who develope shoulder pain at weak limb.
  • Good conscious and able to access pain score.
  • No history of drug reaction with xylocaine
  • No history of fracture,tumor or blood tendency.
  • Willing to enrolled to study and signs inform consent.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of physical medicine and rehabilitation, Faculty of medicien, Chulalongkorn University

Bangkok, Bangkok, Thailand

Location

MeSH Terms

Conditions

Shoulder PainStrokeHemiplegia

Interventions

LidocaineHigh-Energy Shock WavesUltrasonic Therapy

Condition Hierarchy (Ancestors)

ArthralgiaJoint DiseasesMusculoskeletal DiseasesPainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsCerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular DiseasesParalysis

Intervention Hierarchy (Ancestors)

AcetanilidesAnilidesAmidesOrganic ChemicalsAniline CompoundsAminesUltrasonic WavesSoundRadiation, NonionizingRadiationPhysical PhenomenaDiathermyHyperthermia, InducedTherapeutics

Study Officials

  • Jariya Boonhong, physiatist

    Unaffiliation

    PRINCIPAL INVESTIGATOR
0

Study Design

Study Type
interventional
Phase
phase 2
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER

Study Record Dates

First Submitted

August 8, 2008

First Posted

August 12, 2008

Study Start

August 1, 2008

Primary Completion

December 1, 2008

Study Completion

May 1, 2009

Last Updated

November 18, 2009

Record last verified: 2008-08

Locations

TH(1)